GRO [AGRIA] 20-F/A: (Original Filing)

[TABLE OF CONTENTS Explanatory Note ITEM 15 Controls and Procedures Table of Contents EXPLANATORY NOTE Table of Contents ITEM 15. CONTROLS AND PROCEDURES Managements Report on Internal Control over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to], [Certification by the Chief Executive Officer I, Xie Tao, certify that: 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect], [Certification by the Chief Financial Officer I, John Layburn, certify that: 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect], [Certification by the Chief Executive Officer (2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. /s/ Xie Tao Name: Xie Tao Title: Chief Executive Officer c16611exv13w1.htm 4 EX-13.1], [Certification by the Chief Financial Officer (2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. /s/ John Layburn Name: John Layburn Title: Acting Chief Financial Officer c16611exv13w2.htm 5 EX-13.2]

By | 2016-01-10T15:42:20+00:00 May 9th, 2011|Categories: Chinese Stocks, GRO, SEC Original|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] CORRESP: (Original Filing)

[H UNTER T AUBMAN W EISS LLP Louis Taubman (Admitted NY) LTaubman@htwlaw.com Email: May 9, 2011 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2009 File No. 001-34189 Dear Mr. Wyman: Very truly yours, HUNTER TAUBMAN WEISS LLP Attorney at Law cc: Dr.]

By | 2016-03-27T20:58:58+00:00 May 9th, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

GRO [AGRIA] 20-F/A: TABLE OF CONTENTS Explanatory Note ITEM 15 Controls

[TABLE OF CONTENTS Explanatory Note ITEM 15 Controls and Procedures Table of Contents EXPLANATORY NOTE Table of Contents ITEM 15. CONTROLS AND PROCEDURES Managements Report on Internal Control over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to], [Certification by the Chief Executive Officer I, Xie Tao, certify that: 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect], [Certification by the Chief Financial Officer I, John Layburn, certify that: 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect], [Certification by the Chief Executive Officer (2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. /s/ Xie Tao Name: Xie Tao Title: Chief Executive Officer c16611exv13w1.htm 4 EX-13.1], [Certification by the Chief Financial Officer (2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. /s/ John Layburn Name: John Layburn Title: Acting Chief Financial Officer c16611exv13w2.htm 5 EX-13.2]

By | 2016-01-10T15:42:31+00:00 May 9th, 2011|Categories: Chinese Stocks, GRO, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] CORRESP: H UNTER T AUBMAN W EISS LLP Louis

[H UNTER T AUBMAN W EISS LLP Louis Taubman (Admitted NY) LTaubman@htwlaw.com Email: May 9, 2011 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2009 File No. 001-34189 Dear Mr. Wyman: Very truly yours, HUNTER TAUBMAN WEISS LLP Attorney at Law cc: Dr.]

By | 2016-03-27T20:59:53+00:00 May 9th, 2011|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

CPGI [China Shengda Packaging] CORRESP: (Original Filing)

[China Packaging Group Inc. May 9, 2011 Via EDGAR Attn: Tia L. Jenkins Raquel Howard Re: China Shengda Packaging Group Inc. Item 4.01 Form 8-K/A Filed April 28, 2011 File No.: 1-34997 Ladies and Gentlemen: For the Staff’s convenience, the comment is included herein and followed by our response. Form 8-K/A filed April 28, 2011 1. Response May 9, 2011]

CPGI [China Shengda Packaging] CORRESP: China Packaging Group Inc. May 9, 2011 Via

[China Packaging Group Inc. May 9, 2011 Via EDGAR Attn: Tia L. Jenkins Raquel Howard Re: China Shengda Packaging Group Inc. Item 4.01 Form 8-K/A Filed April 28, 2011 File No.: 1-34997 Ladies and Gentlemen: For the Staff’s convenience, the comment is included herein and followed by our response. Form 8-K/A filed April 28, 2011 1. Response May 9, 2011]

By | 2016-03-08T22:28:10+00:00 May 9th, 2011|Categories: Chinese Stocks, CPGI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar